Web Analytics Made Easy - StatCounter
Galt stock analysis
<

Analyst Firms Making Recommendations

Galectin Therapeutics, Inc. - GALT Stock Chart Technical Analysis for 06-08-18

Detailed Estimates

GNFTF Stock Price Reaction to Subscription Rights Offering

Fewer Developed New Varices

Price / Earnings (2019)

Galectin Therapeutics Inc - GALT Stock Chart Technical Analysis for 12-08-17

Galectin Therapeutics Inc - GALT Stock Chart Technical Analysis for 09-21-16

Earnings Growth (2019)

Estimate momentum measures changes in analyst sentiment over time & may be an indicator of future price movements.

Galectin Therapeutics Inc - GALT Stock Chart Technical Analysis for 11-10-16

Earnings Surprise

The recent performance of Galectin Therapeutics (NASDAQ:GALT) stock in the market spoke loud and clear to investors as GALT saw more than 360.30K shares in ...

3 Stocks That Could Double Your Money

The subset of patients without varices greatly benefitted from an anomaly in results of patients receiving a placebo. Further, the actual percent change in ...

Providence Clinical Conclusions

Learn Day Trading Strategies: A Continued Breakout: $GALT. Stock Market Video

Statistical Analysis

What Type Of Shareholder Owns Galectin Therapeutics, Inc.'s (NASDAQ:GALT)?

NasdaqCM:GALT Insider Trading Nov 6th 17

Galectin Therapeutics (GALT) Jumps: Stock Rises 15.1%

CT Scan Resolution Melanoma Deposit

Is the Options Market Predicting a Spike in Galectin Therapeutics (GALT) Stock?

Portal Pressure

Galectins in Disease A to Z

Is the Options Market Predicting a Spike in Galectin Therapeutics (GALT) Stock?

Video Thumbnail

Journal of Nature and Science of Medicine, College of Medicine, King Saud University

Galectin Therapeutics, Inc. (GALT) in Focus: Stock Moves Up 8.84% - Tale of the Tape

GALT Update – Rights Offering

$ACRX $AXAS $ENPH $GALT Tomorrow's WL!

View photos

Download figure ...

Multiple Pet Scan Melanoma Deposits Resolved

See our latest analysis for GALT · NasdaqCM:GALT Ownership Summary Nov 6th 17

Legg Mason Could be Hurt by Higher Outflows and Expenses

Leave a comment and click here to sub for MS Equity Analysis and Swing Moves.

The glycosylation landscape of pancreatic cancer

Why General Motors (GM) is Such a Great Value Stock Pick Right Now

Multiple Melanoma Deposits Resolved

Is the Options Market Predicting a Spike in Galectin Therapeutics (GALT) Stock?

2 Clinical-Stage Biotech Stocks That Could Soar Next Week

NASDAQCM:GALT

Is Galectin Therapeutics (GALT) Stock Outpacing Its Medical Peers This Year?

The world's flagship neutron science facility, Institut Laue-Langevin (ILL), shares

Interestingly, the results presented by GALT indicate the therapy may prevent patients from progressing to varices and other complications of cirrhosis, ...

Video Thumbnail

FIG 5 Growth of galT , galT glpR , and glpR mutant cells in M63 broth

Waterfall plot of best clinical response (RECIST 1.1) post-treatment. Dotted line at -30% change from baseline indicates the RECIST 1.1 threshold for ...

(click to enlarge) 1058124-14844273338148081.jpg

The Performance That We've Seen From GALT

Emerging Growth Biotechnology Company

Geometric Average=Compound Avg Ann Return

GSP® Neonatal GALT kit

Implied Volatility Surging for Galectin Therapeutics (GALT) Stock Options

Galactose-1-Phosphate Uridyltransferase Activities in Different Genotypes: A Retrospective Analysis of 927 Samples | The Journal of Applied Laboratory ...

CT Resolution Lung Melanoma Deposit

GALT Announces Extension of Retention Bonuses

Galectin Therapeutics (GALT) in Focus: Stock Moves 6.5% Higher

This Analyst Remains Positive on Galectin Therapeutics Inc (GALT) Even as He Slashes Price Target

Nucleoside effect on growth of galT mutant cells in M63 minimal medium... | Download Scientific Diagram

3 easy ways to find momentum stocks with Finviz

GRAPHIC

Download figure ...

Video Thumbnail

What You Must Know About Galectin Therapeutics Inc's (GALT) Major Investors

Galectin Therapeutics (GALT) Presents At H.C. Wainwright & Co. Annual Global Life Sciences Conference - Slideshow - Galectin Therapeutics, ...

Galectin Therapeutics, Inc. (GALT) Stock Chart Technical Analysis

GRAPHIC

Walk Drive Fly Products Copyright 2002 John Galt Solutions, Inc.

GALT.jpg

Who Is John Galt?: A Navigational Guide to Ayn Rand's Atlas Shrugged Paperback – October 21, 2013

Galectin Therapeutics Inc (NASDAQ:GALT) share price plunged -8.77% or -0.10 points to reach at $1.04 during previous trading session. The stock's price ...

After Hours Market Analysis | $MRNS $MYO $GALT

Are Options Traders Betting on a Big Move in Galectin Therapeutics (GALT) Stock?

(click to enlarge) 1058124-14844350124126272.jpg

279153569.jpg

View photos

FIG 4 MAT analysis of the transcriptome of galT mutant cells grown in.

Don't Let Fear Of Missing Out Drive Investment Decisions: Fate Therapeutics, Inc. (FATE), Galectin Therapeutics, Inc. (GALT) | GV Times

pages_Page_13.jpg

Download figure ...

Innovation Pharmaceuticals Inc - IPIX Stock Chart Technical Analysis for 12-08-17

WT and GALT null rats were treated daily with AT-007 for five months, beginning on the day after birth, and were tested for cognitive outcomes via rotarod ...

GALT & TAGGART Successfully releases two-years long obligations, worth 15 million GEL

Click here to view the form 8-K and presentation. On March 06, 2019 GALT filed registration statements of a rights offering of common stock and …

... headlines quite a bit as key readouts from Madrigal (MDGL) and Galmed (GLMD) teased the markets with their efficacy. Galectin Therapeutics (GALT) which ...

Implied Volatility Surging for Galectin Therapeutics (GALT) Stock Options

ForecastX Demo Video

There is no change to the longer-term outlook whereby I believe an ABC corrective pattern is in play with price currently tracing out its way to a wave B ...

Innovation Pharmaceuticals Inc - IPIX Stock Chart Technical Analysis for 12-08-17

This chart was shown in previous analysis back in June 2016. That analysis outlined the expectation for a top this quarter. So far that appears to be the ...

Recent third-party research bodes well for GALT's GR-MD-02. GR

Galectin Blocker is Front Runner in Fight Against NASH-Cirrhosis

GRAPHIC

... NASDAQ:GALT 4; 5.

Insider Weekends: Richard Kinder Adds To His Stake In Kinder Morgan